 | Jerry Menikoff, Edward P. Richards - 2006 - 336 páginas
...JAMA 925 (1997). 37. See, eg, Temple and Ellenberg, supra note 34; Robert Temple and SS Ellenberg, Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments. Part 2: Practical Issues and Specific Cases, 133 Ann. Int. Med. 464 (2000); Robert J. Temple, When Are Clinical... | |
 | Eli Minkoff, Eli Baker - 2007 - 928 páginas
...Available online at http://www.wma .net/e/policy/b3 .htm#note 1 . Accessed November 5, 2005 30. Temple R, Ellenberg SS. Placebo-controlled trials and active-control...ethical and scientific issues. Ann Intern Med 2000; 133: 455-63 31. Lublin FD, Baier M, Cutter G. Effect of relapses on development of residual deficit in multiple... | |
 | Karen F. Greif, Jon F. Merz - 2007 - 401 páginas
...at <http://www.wma. net/e/policy/b3.htm> (accessed April 16, 2005). 6. Ellenberg. SS, and R. Temple. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 2: Practical issues and specific cases. Annals of Internal Medicine 133 (2000): 464^70. 7. Connor,... | |
 | Alan M. Pearson, Marie Isabelle Chevrier, Mark Wheelis - 2007 - 346 páginas
...and Scientific Issues," Annals of Internal Medicine 133 (2000): 455-63; R. Temple and S. Ellenberg, "Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments. Part 2: Practical Issues and Specific Cases," Annals of Internal Medicine 133 (2000): 464-70. 10. MJ Schmidt,... | |
 | Kim T. Mueser, Dilip V. Jeste - 2008 - 673 páginas
...Transforming the clinical method (2nd ed.). Oxon, UK: Radcliffe. Temple, R., & Ellenberg, SS (2000). Placebo-controlled trials and active-control trials...treatments: Part 1. Ethical and scientific issues. Annals of Internal Medicine, 133, 455-463. Twamley, EW, Jeste, DV, & Bellack, AS (2003). A review of... | |
 | James L. Bernat - 2008 - 552 páginas
...Part 1. Ethical and scientific issues. Ann Intern Med 2000:133:455-463 and Ellenberg SS, Temple R. Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 2. Practical issues and specific cases. Ann Intern Med 2000;1 33:464-470. An international task force... | |
| |
Placebo-controlled trials and active-control trials in the evaluation of new treatments. Part 1: ethical and scientific issues. 
